Open access
Sep 2026
A Trojan horse nanoplatform overcoming delivery barriers for targeted gene immunotherapy of colorectal cancer
Programmed cell death ligand 1 (PD-L1) antibody has been shown to hold tremendous promise in curing metastatic colorectal cancer (CRC). However, the delivery efficacy of the targeted biologics limits this immunotherapy in a subset of CRC. Here we report a novel biomimetic ‘Trojan horse’ nano-delivery system for targe...
Yao Wang, Yong-Jie Yu, Qing-Yan Deng et al.
· Frontiers in Bioengineering... · 0 citations